Meme Manyetik Rezonans Görüntülemesi: Güncel Uygulamalar

Memenin manyetik rezonans görüntülemesi MRG tüm meme görüntüleme yöntemlerinden daha yüksek bir duyarlılığa sahip olması nedeniyle, tarama, tanı, evreleme ve tedavi amaçlı yaygın olarak kullanılmaya başlamıştır. Doğru teknikle yapılmış bir MRG incelemesi; meme kanseri tanısı almış olgularda pre-operatif inceleme ya da neoadjuvan kemoterapi değerlendirmesinde, diğer radyolojik yöntemler ile kesin tanısı konulamayan olgularda problem çözücü olarak, meme kanseri açısından yüksek risk taşıyan kadınlarda tarama amaçlı, post-operatif memenin değerlendirmesinde, mammoplasti, implant ve rekonstrüksiyon sonrası görüntülemede kullanılarak klinik yaklaşımı değiştirecek kararlar alınmasına yardımcı olmaktadır. Bu derleme, meme MRG’nin endikasyonlarını güncel kılavuzlar eşliğinde ele alarak irdelemeyi amaçlamaktadır

Breast Magnetic Resonance Imaging: Current Applications

Since breast magnetic resonance imaging MRI has higher sensitivity than any other breast imaging modality, it is widely used for the screening, diagnosis and staging purposes. If breast MRI is obtained with the proper technique, it is useful in the pre-operative assessment of patients diagnosed with breast cancer or for the neoadjuvant chemotherapy, as a problem solver in cases which remain equivocal after thorough evaluation with the other radiological modalities, as a screening method for women with high risk of developing breast cancer, in the evaluation of post-operative breast, mammoplasty, implant evaluation, and after reconstruction, since it helps decision making in patient management. This review aims to evaluate the indications of breast MRI while discussing the current guidelines

___

Smith RA, Duffy SW, Tabár L. Breast cancer screening: the evolving evidence. Oncology (Williston Park). 2012 May;26(5):471-5, 479- 81, 485-6.

Bock K, Borisch B, Cawson J, Damtjernhaug B, de Wolf C, Dean P, et. al.Effect of population-based screening on breast cancer mortality. Lancet. 2011 Nov 19;378(9805):1775-6.

Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et. al. Swedish two- county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011 Sep;260(3):658-63.

Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, et. al. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer. 2011 Feb 15;117(4):714-22.

Bloom S, Morrow M. A clinical oncologic perspective on breast magnetic resonance imaging.MagnReson Imaging Clin N Am. 2010 May;18(2):277-94.

Siegmann KC, Kramer B, Claussena C. Current status and new developments in breast MRI. Breast Care (Basel) 2011;6(2):87–92

Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. EurRadiol. 2008 Jul;18(7):1307-18.

Brandão AC, Lehman CD, Partridge SC. Breast magnetic resonance imaging: diffusion-weighted imaging. MagnReson Imaging Clin N Am. 2013 May;21(2):321-36.

Warren RM, Pointon L, Thompson D, et al. Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. Radiology 2005;236:779–88.

American College of Radiology BI-RADS(r)-MRI. BI-RADS (r) Atlas. 1 ed. Reston: American College of Radiology 2003

Peters NH, BorelRinkes IH, Zuithoff NP, et al. Meta- analysis of MR imaging in the diagnosis of breast lesions. Radiology 2008;246:116–24.

Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, et. al. Diagnostic architectural and dynamic features at breast MR imag- ing: multicenter study. Radiology 2006;238:42–53

nal staging. J Okla State Med Assoc 2006;99:505–515

Liberman L, Morris EA, Dershaw DD, Abramson AF, Tan LK MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 2003;180:901–910

Ikeda O, Nishimura R, Miyayama H, Yasunaga T, Ozaki Y, Tsuji A, Yamashita Y Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer. ActaRadiol 2004;45:721–725

Satake H, Shimamoto K, Sawaki A, Niimi R, Ando Y, Ishiguchi T, Ishigaki T, Yamakawa K, Nagasaka T, FunahashiH Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging. EurRadiol 2000;10:1726–1732

Lee SG, Orel SG, Woo IJ, Cruz-Jove E, Putt ME, Solin LJ, Czerniecki BJ, SchnallMD MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003;226:773–778

Lehman CD, Gatsonis C, Kuhl CK, Hendrick RE, Pisano ED, Hanna L, Peacock S, Smazal SF, Maki DD, Julian TB, DePeri ER, Bluemke DA, SchnallMD MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007;356:1295–1303

Liberman L, Morris EA, Kim CM, Kaplan JB, Abramson AF, Menell JH, Van Zee KJ, Dershaw DD MR imaging findings in the contralateral breast of women with recently diag- nosed breast cancer. AJR Am J Roentgenol 2003; 180:333–341

Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, Pronio AM, Kirchin MA, PassarielloR Contrast-enhanced MR mam- mography for evaluation of the contra- lateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 2007;243:670–680

Slanetz PJ, Edmister WB, Yeh ED, Talele AC, KopansDB Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 2002;8:145–14

Quan ML, Sclafani L, Heerdt AS, Fey JV, Morris EA, BorgenPI Magnetic resonance imaging detects unsuspected disease in patients with invasive lobular cancer. Ann SurgOncol 2003;10:1048–1053

Schelfout K, Van Goethem M, Kersschot E, Verslegers I, Biltjes I, Leyman P, Colpaert C, Thienpont L, Van Den Haute J, Gillardin JP, Tjalma W, Buytaert P, De SchepperA Preoperative breast MRI in patients with invasive lobular breast cancer. EurRadiol 2004;14:1209–1216

Fabre Demard N, Boulet P, Prat X, Charra L, Lesnik A, TaourelP Breast MRI in invasive lobular carcinoma: diagnosis and staging. J Radiol 2005;86:1027–1034

Mann RM, Hoogeveen YL, Blickman JG, BoetesC MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: a review of existing literature. Breast Cancer Res Treatment 2008;107(1):1–14

Morris EA, Schwartz LH, Dershaw DD, Van Zee KJ, Abramson AF, Liberman L MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997;205:437–440

Orel SG, Weinstein SP, Schnall MD, Reynolds CA, Schuchter LM, Fraker DL, SolinLJ Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999;212:543–549

D’Orsi CJ, Newell MS. BI-RADS decoded: detailed guidance on potentially confusing issues. RadiolClin North Am. 2007 Sep;45(5):751-63

Leung JW. MR imaging in the evaluation of equivocal clinical and imaging findings of the breast.MagnReson Imaging Clin N Am. 2010 May;18(2):295-308

Yau EJ, Gutierrez RL, DeMartini WB, Eby PR, Peacock S, Lehman CD. The utility of breast MRI as a problem-solving tool. Breast J. 2011 May-Jun;17(3):273-80.

Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004 Dec;233(3):830-49.

Bazzocchi M, Zuiani C, Panizza P, Del Frate C, Soldano F, Isola M, et al. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. AJR Am J Roentgenol. 2006 Jun;186(6):1723-32.

Cilotti A, Iacconi C, Marini C, Moretti M, Mazzotta D, Traino C, et al. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications. Radiol Med. 2007 Mar;112(2):272-86.

Lee CH, Smith RC, Levine JA, Troiano RN, Tocino I. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram. AJR Am J Roentgenol. 1999 Nov;173(5):1323-9.

Moy L, Elias K, Patel V, Lee J, Babb JS, Toth HK, et al. Is breast MRI helpful in the evaluation of inconclusive mammographic findings? AJR Am J Roentgenol. 2009 Oct;193(4):986-93.

Ozcan UA, Ocak F, Altun E. Can breast MRI facilitate decision-making in equivocal mammography and ultrasonography findings? Eur J Radiol. 2012 Sep;81Suppl 1:S112-3.

Sardanelli F, Boetes C, Borisch B, Decker T, Federico M, Gilbert FJ, Helbich T, Heywang-Köbrunner SH, Kaiser WA, Kerin MJ, Mansel RE, Marotti L, Martincich L, Mauriac L, Meijers-Heijboer H, Orecchia R, Panizza P, Ponti A, Purushotham AD, Regitnig P, Del Turco MR, Thibault F, Wilson R.Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer. 2010 May;46(8):1296-316.

Baltzer PA, Dietzel M, Kaiser WA.MR-spectroscopy at 1.5 tesla and 3 tesla. Useful? A systematic review and meta-analysis.Eur J Radiol. 2012 Sep;81Suppl 1:S6-9.

Kuhl CK. Breast MR imaging at 3T. MagnReson Imaging Clin N Am. 2007 Aug;15(3):315-20, vi.

Tsougos I, Svolos P, Kousi E, Athanassiou E, Theodorou K, Arvanitis D, Fezoulidis I, VassiouK.The contribution of diffusion tensor imaging and magnetic resonance spectroscopy for the differentiation of breast lesions at 3T. ActaRadiol. 2014 Feb 1;55(1):14-23.

Acıbadem Üniversitesi Sağlık Bilimleri Dergisi-Cover
  • ISSN: 1309-470X
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2010
  • Yayıncı: ACIBADEM MEHMET ALİ AYDINLAR ÜNİVERSİTESİ